Kelly · 10 hours ago
Head of Immunotherapy Corporate Strategy
LA Metro Area
Full-time
Onsite
Director/Executive
$175K/yr - $245K/yr
7+ years expKelly Science & Clinical is seeking a dynamic and visionary Director/Senior Director of Business Development & Corporate Strategy for a leading advanced therapeutics company. This role involves driving transformative partnerships, acquisition strategies, and external innovation initiatives to expand the organization's global portfolio of high-impact assets.
OutsourcingProfessional Services
Hiring Manager
Alexandre Neves, Ph.D.
Responsibilities
Serve as a core architect of corporate strategy, proactively identifying external innovation, investment, and partnership opportunities that align with the organization’s long-term vision
Lead the end-to-end process for strategic transactions—including search, evaluation, and execution of transformative deals focused on first-in-class or highly differentiated assets across advanced therapeutic modalities (e.g., antibody-drug conjugates, cellular platforms)
Scout, assess, and secure clinical- to commercial-stage assets, with a focus on late-stage programs in immunotherapy, oncology, urology, and advanced biologics
Conduct rigorous scientific and commercial due diligence, collaborating cross-functionally with Clinical, Regulatory, CMC, IP, Finance, and Commercial teams
Develop robust market forecasts, valuation models, scenario analyses, and competitive landscape reviews to support decision-making and maximize portfolio value
Partner with internal stakeholders to ensure holistic asset evaluation and optimal integration
Spearhead development and execution of the company’s CDMO (Contract Development & Manufacturing Organization) growth strategy, positioning proprietary manufacturing expertise as a critical partner for emerging and established biotechnology companies
Identify, engage, and secure CDMO collaboration opportunities—structuring creative proposals and solutions that leverage technical and operational strengths
Work closely with Technical Operations, Quality, and Regulatory colleagues to ensure alignment around timelines, operational feasibility, and partner success
Represent the company at key industry and client-facing conferences, building new relationships and advocating for the value proposition of its CDMO capabilities
Lead the structuring, negotiation, and closing of term sheets and definitive agreements for business development and CDMO transactions
Orchestrate comprehensive due diligence and contract development processes, ensuring internal alignment and governance throughout transaction lifecycles
Advise the CEO and Executive Team on corporate strategy formulation, growth initiatives, and long-range portfolio planning
Prepare and present executive summaries, board materials, and strategic recommendations based on real-time market intelligence and opportunity assessments
Qualification
Required
7-10+ years of progressive business development experience in the biotechnology or pharmaceutical sector
Proven track record executing business development, M&A, licensing, or investment transactions from origination through closing
Advanced degree required (MBA, PhD, MD, or equivalent scientific/business discipline)
Strong understanding of advanced therapeutic modalities, including ADCs, biologics, cell and gene therapies, or complex drug platforms
Deep financial expertise in valuation modeling, risk/return analysis, and sophisticated deal structuring
Exceptional executive presence and communication skills; able to build trust and influence across diverse internal and external audiences
High-impact cross-functional leadership and stakeholder management capabilities, engaging teams across Clinical, Operations, Regulatory, Legal, and Commercial
A robust deal sheet evidencing successful high-value transactions
Willingness and ability to travel up to 50%, including international destinations
Preferred
Experience with board-level communications or presenting to investment committees
Direct leadership or support of CDMO business development or strategic alliances
Established network within the biotech venture capital/private equity ecosystem
Expertise in immuno-oncology, cellular therapies, urology, or related advanced modalities
Background in consulting or operations within high-growth or commercial-stage biopharma environments
Experience navigating and partnering within international biopharma markets, especially in China
Prior experience in life sciences-focused investment banking, venture capital, or private equity settings
Company
Kelly
We’ve been helping organizations find the people they need longer than any other company in the world.
10001+ employees
H1B Sponsorship
Kelly has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (85)
2024 (76)
2023 (59)
2022 (74)
2021 (81)
2020 (65)
Funding
Current Stage
Public CompanyTotal Funding
unknown1978-01-13IPO
Leadership Team
Chris Layden
Chief Executive Officer
N
Nicholas Zuhlke
Vice President, Controller, and Chief Accounting Officer
Recent News
Kelly Services, Inc.
2025-11-08
2025-11-08
Company data provided by crunchbase